RxDoctor Payments Data

Steven Lasser, MD

Orthopaedic Surgery of the Spine · Geneva, NYNPI 1750302048

Payments from drug & device makers

$6,631in general payments, 2019–2025

Across 89 payments — averaging $74.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$4K
  • Medical Device Business Services, Inc.$502
  • Kerecis Limited$398
  • Heron Therapeutics, Inc.$219
  • Atricure, Inc.$166
  • Acumed LLC$158
  • plus $811 from 10 others

What the payments were for

  • Speaking & faculty fees$240%
  • Travel & lodging$1,24619%
  • Food & beverage$5,22379%
  • Education$1372%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,631 in reported general payments places this provider in the 35th percentile of 161 orthopaedic surgery of the spine providers in New York.

See all orthopaedic surgery of the spine providers in New York

Medicare billing

Part B allowed, 2024
$14,096
Medicare patients
35
Services billed
73

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin17$144
Tramadol Hcl12$59

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Geneva

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →